Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Anand Krishnan is Principal Investigator in Chemical Pathology at the Faculty of Health Sciences, University of the Free State, South Africa, where he leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories. His research focuses on the biological functions of extracellular vesicles in synthetic biology, including cell surface protein modification, biomarker discovery using liquid biopsy-derived extracellular vesicles, and the role of circulating biomarkers in disease development and stem cell biology. He leads multidisciplinary research in precision medicine and nanoscale diagnostics, with a particular interest in translational applications of extracellular vesicle science. Krishnan is an active member of the International Society for Extracellular Vesicles, the African Organisation for Research and Training in Cancer, and the American Association for Cancer Research. He has also served in editorial roles supporting scientific research and publishing.

Select Guide Rating

• 1. Introduction2. siRNA and miRNA therapies for leukaemia3. Gene therapy for leukaemia4. Exploring Polymeric nanoparticles in leukaemia management5. Magnetic Nanoparticles in Leukemia Therapy: Advancements and Future Directions6. Mesoporous Silica Nanoparticles: A Novel Approach in Targeted Leukemia Therapy7. Targeted Leukemia Therapy with Solid Lipid Nanoparticles: Potential and Progress8. The Role of Exosomes in Leukemia Treatment: Advancements in Biomarker Discovery and Drug Delivery9. Nanoemulsion-Based Drug Delivery in Leukemia: Potential and Progress in Therapeutic Applications10. Advances in Leukemia Treatment using Micelles and Dendrimers11. Revolutionizing Leukemia Therapy with Liposomes and Niosomes: Targeted Delivery and Improved Efficacy12. Biological and immunological aspects of nanocarriers and nano-vaccines13. Leveraging AI and machine learning for prostate cancer management 14. Role of DNA Origami and mRNA/siRNA nanocarriers in prostate cancer

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Anand Krishnan is Principal Investigator in Chemical Pathology at the Faculty of Health Sciences, University of the Free State, South Africa, where he leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories. His research focuses on the biological functions of extracellular vesicles in synthetic biology, including cell surface protein modification, biomarker discovery using liquid biopsy-derived extracellular vesicles, and the role of circulating biomarkers in disease development and stem cell biology. He leads multidisciplinary research in precision medicine and nanoscale diagnostics, with a particular interest in translational applications of extracellular vesicle science. Krishnan is an active member of the International Society for Extracellular Vesicles, the African Organisation for Research and Training in Cancer, and the American Association for Cancer Research. He has also served in editorial roles supporting scientific research and publishing.

Select Guide Rating

• 1. Introduction2. siRNA and miRNA therapies for leukaemia3. Gene therapy for leukaemia4. Exploring Polymeric nanoparticles in leukaemia management5. Magnetic Nanoparticles in Leukemia Therapy: Advancements and Future Directions6. Mesoporous Silica Nanoparticles: A Novel Approach in Targeted Leukemia Therapy7. Targeted Leukemia Therapy with Solid Lipid Nanoparticles: Potential and Progress8. The Role of Exosomes in Leukemia Treatment: Advancements in Biomarker Discovery and Drug Delivery9. Nanoemulsion-Based Drug Delivery in Leukemia: Potential and Progress in Therapeutic Applications10. Advances in Leukemia Treatment using Micelles and Dendrimers11. Revolutionizing Leukemia Therapy with Liposomes and Niosomes: Targeted Delivery and Improved Efficacy12. Biological and immunological aspects of nanocarriers and nano-vaccines13. Leveraging AI and machine learning for prostate cancer management 14. Role of DNA Origami and mRNA/siRNA nanocarriers in prostate cancer

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Anand Krishnan is Principal Investigator in Chemical Pathology at the Faculty of Health Sciences, University of the Free State, South Africa, where he leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories. His research focuses on the biological functions of extracellular vesicles in synthetic biology, including cell surface protein modification, biomarker discovery using liquid biopsy-derived extracellular vesicles, and the role of circulating biomarkers in disease development and stem cell biology. He leads multidisciplinary research in precision medicine and nanoscale diagnostics, with a particular interest in translational applications of extracellular vesicle science. Krishnan is an active member of the International Society for Extracellular Vesicles, the African Organisation for Research and Training in Cancer, and the American Association for Cancer Research. He has also served in editorial roles supporting scientific research and publishing.

Select Guide Rating

• 1. Introduction2. siRNA and miRNA therapies for leukaemia3. Gene therapy for leukaemia4. Exploring Polymeric nanoparticles in leukaemia management5. Magnetic Nanoparticles in Leukemia Therapy: Advancements and Future Directions6. Mesoporous Silica Nanoparticles: A Novel Approach in Targeted Leukemia Therapy7. Targeted Leukemia Therapy with Solid Lipid Nanoparticles: Potential and Progress8. The Role of Exosomes in Leukemia Treatment: Advancements in Biomarker Discovery and Drug Delivery9. Nanoemulsion-Based Drug Delivery in Leukemia: Potential and Progress in Therapeutic Applications10. Advances in Leukemia Treatment using Micelles and Dendrimers11. Revolutionizing Leukemia Therapy with Liposomes and Niosomes: Targeted Delivery and Improved Efficacy12. Biological and immunological aspects of nanocarriers and nano-vaccines13. Leveraging AI and machine learning for prostate cancer management 14. Role of DNA Origami and mRNA/siRNA nanocarriers in prostate cancer